Our Technology
The SynerFuse® e-TLIF™ procedure incorporates input from the company’s medical team of surgeons and learnings from our completed proof-of-concept (POC) study. This enables our NeuroFuse® System to provide Ultra Low Energy (ULE) therapy for direct nerve stimulation at the point of spine fusion. The NeuroFuse® System consists of an implantable pulse generator (“IPG”), a multi-channel lead to deliver electrical impulses from the IPG to the spine, and a mobile device application to enable individualized programming of the IPG. Plus a clinician programmer to allow for remote programming and monitoring of the patient via WIFI.

• Patient-Focused Integrated Solution
  With our patented SynerFuse® e-TLIF™ procedure, we hope to help people live without pain by making traditional spine implant surgery more successful and cost effective by combining neuromodulation at the time surgeons are performing fusion back surgery.

• Surgeon-Centric
  Treat Neuropathic Pain at the Same Spinal Level as the Spine Surgery with single incision to maximize surgeon outcomes. Stim designed for surgeons.

• Fusion Hardware-Agnostic
  Add-on to any fusion hardware that surgeons prefer.

Strategic Partnership with Velentium Medical to support our build, design, and manufacturing of the NeuroFuse System.
A strategic partnership that brings together the necessary technical skills and technological innovations to enable SynerFuse® ULE Therapy.

Simulation of the e-TLIF™ Procedure that allows for ULE Therapy

Broad Patent Coverage to Enable Novel Innovation
SynerFuse® has 11 patents issued including the United States, Canada, and Australia. The SynerFuse® IP strategy protects key aspects of our concept and technology across the globe to enable our novel approach to solving chronic back pain.